Quarterly report pursuant to Section 13 or 15(d)

Debt - Narrative (Details)

v3.3.0.814
Debt - Narrative (Details)
1 Months Ended 3 Months Ended 9 Months Ended
Nov. 05, 2015
USD ($)
Oct. 01, 2015
d
conversion_right
$ / shares
Aug. 30, 2013
USD ($)
conversion_right
shares
Jan. 31, 2013
USD ($)
$ / shares
May. 31, 2015
USD ($)
shares
Mar. 31, 2015
USD ($)
$ / shares
shares
Jun. 30, 2014
USD ($)
shares
Jan. 31, 2013
USD ($)
$ / shares
Jun. 30, 2015
conversion_right
Mar. 31, 2015
d
$ / shares
Sep. 30, 2015
USD ($)
institution
$ / shares
shares
Sep. 30, 2014
USD ($)
Dec. 31, 2014
USD ($)
institution
Debt Instrument [Line Items]                          
Interest paid                     $ 2,917,000 $ 5,222,000  
Gains (losses) on extinguishment of debt                     943,000 $ 2,668,000  
Gain (loss) on embedded derivative                     31,800,000    
Credit line capacity                     $ 134,961,000    
Number of financial institutions | institution                     10   12
OPKO Health Europe                          
Debt Instrument [Line Items]                          
Weighted average interest rate                     3.30%   3.40%
Minimum | OPKO Health Europe                          
Debt Instrument [Line Items]                          
Variable interest rates                     2.70%    
Maximum | OPKO Health Europe                          
Debt Instrument [Line Items]                          
Variable interest rates                     6.30%    
Notes                          
Debt Instrument [Line Items]                          
Convertible notes, conversion                     $ 55,442,000    
Long-term Debt                     $ 44,206,000   $ 131,454,000
Notes | Notes Due February 1, 2033                          
Debt Instrument [Line Items]                          
Debt face amount       $ 175,000,000.0       $ 175,000,000.0          
Interest rate of notes payable       3.00%       3.00%     3.00%    
Equivalent redemption price       100.00%       100.00%          
Conversion Rate     141.4827 141.48             141.4827    
Conversion Price | $ / shares       $ 7.07   $ 7.07   $ 7.07   $ 7.07 $ 7.07    
Number of trading days | d                   20      
Convertible debt, threshold percentage of stock price trigger               130.00%   130.00%      
Number of consecutive trading days applicable conversion price                   30 days      
Conversion right triggered | conversion_right     1           1        
Convertible notes, conversion     $ 16,900,000     $ 36,400,000 $ 70,400,000            
Convertible debt, stock issued from conversion | shares     2,396,145   726,036           2,028,130    
Interest paid           200,000 $ 800,000            
Gains (losses) on extinguishment of debt         $ 30,000 $ (300,000)         $ 1,200,000    
Converted amount         $ 5,000,000           14,000,000    
Common stock trigger price | $ / shares                   $ 9.19      
Long-term Debt                     32,200,000    
Notes | Notes Due February 1, 2033 | Subsequent Event                          
Debt Instrument [Line Items]                          
Conversion Rate   141.4827                      
Conversion Price | $ / shares   $ 7.07                      
Number of trading days | d   20                      
Convertible debt, threshold percentage of stock price trigger   130.00%                      
Number of consecutive trading days applicable conversion price   30 days                      
Conversion right triggered | conversion_right   1                      
Common stock trigger price | $ / shares   $ 9.19                      
Notes | Notes Due February 1, 2033 | Minimum                          
Debt Instrument [Line Items]                          
Number of trading days applicable conversion price               20 days          
Notes | Notes Due February 1, 2033 | Maximum                          
Debt Instrument [Line Items]                          
Number of consecutive trading days applicable conversion price               30 days          
Notes | Notes Due February 1, 2033 | On or after February 1, 2017 and before February 1, 2019                          
Debt Instrument [Line Items]                          
Equivalent redemption price               100.00%          
Line of Credit                          
Debt Instrument [Line Items]                          
Early termination fee                     500,000    
Amount outstanding                     $ 67,900,000    
Weighted average interest rate                     4.60%   6.10%
Line of Credit | Bio-Reference                          
Debt Instrument [Line Items]                          
Credit line capacity                     $ 120,000,000    
Eligible receivables percentage                     50.00%    
Line of Credit | Minimum                          
Debt Instrument [Line Items]                          
Interest rate at period end                     3.50%    
Line of Credit | Maximum                          
Debt Instrument [Line Items]                          
Interest rate at period end                     7.58%    
Common stock investments, available for sale | Notes | Notes Due February 1, 2033                          
Debt Instrument [Line Items]                          
Convertible debt, stock issued from conversion | shares           5,363,896 10,974,431            
Revolving Credit Facility | Line of Credit | New Credit Agreement | Subsequent Event                          
Debt Instrument [Line Items]                          
Credit line capacity $ 175,000,000.0                        
Higher borrowing capacity option $ 275,000,000.0                        
Commitment fee percentage 0.25%                        
Swingline | Line of Credit | New Credit Agreement | Subsequent Event                          
Debt Instrument [Line Items]                          
Credit line capacity $ 20,000,000.0                        
Letter of Credit | Line of Credit | New Credit Agreement | Subsequent Event                          
Debt Instrument [Line Items]                          
Credit line capacity $ 20,000,000.0                        
LIBOR | Revolving Credit Facility | Line of Credit | New Credit Agreement | Subsequent Event                          
Debt Instrument [Line Items]                          
Basis spread on variable rate 2.50%                        
LIBOR, First 12 Months | Revolving Credit Facility | Line of Credit | New Credit Agreement | Subsequent Event                          
Debt Instrument [Line Items]                          
Basis spread on variable rate 0.35%                        
LIBOR Thereafter | Revolving Credit Facility | Line of Credit | New Credit Agreement | Subsequent Event                          
Debt Instrument [Line Items]                          
Basis spread on variable rate 0.50%                        
LIBOR, First 12 Months, Adjusted for Eurocurrency Liabilities | Revolving Credit Facility | Line of Credit | New Credit Agreement | Subsequent Event                          
Debt Instrument [Line Items]                          
Basis spread on variable rate 1.35%                        
LIBOR, Thereafter, Adjusted for Eurocurrency Liabilities | Revolving Credit Facility | Line of Credit | New Credit Agreement | Subsequent Event                          
Debt Instrument [Line Items]                          
Basis spread on variable rate 1.50%